Viking Long Fund Master Ltd.'s Net Worth

Estimate Recalculated Jun 30, 2025 09:50PM EST

Who is Viking Long Fund Master Ltd.

Viking Long Fund Master Ltd. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Wayfair Inc., FIRST DATA CORP, Adaptive Biotechnologies Corp, Editas Medicine, Inc., Arbutus Biopharma Corp, Myovant Sciences Ltd., Roivant Sciences Ltd., Urovant Sciences Ltd., Axovant Sciences Ltd., and BridgeBio Pharma, Inc..

SEC CIK

Viking Long Fund Master Ltd.'s CIK is 0001621596

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adaptive Biotechnologies Corp

Investor

Updated Dec 16, 2020

View Quote Details


Form 4	-3.23%	-1.00M	$55.65	-$55.65M	Dec 16, 2020	29.99M	Sale	—	Dec 14
Form 4	-7.46%	-2.50M	$49.52	-$123.79M	Nov 13, 2020	30.99M	Sale	—	Nov 11
Form 4	-12.79%	-4.91M	$24.98	-$122.71M	Jan 30, 2020	33.49M	Sale	—	Jan 28
Form 4	0.66%	250.00K	$20.00	—	Jul 02, 2019	38.41M	Purchase	—	Jul 01
Form 3	—	—	—	—	Jun 26, 2019	1.43M	—	—	—

Showing 5 results

FIRST DATA CORP

Investor

Updated Apr 15, 2016


Form 4	—	—	—	—	Apr 15, 2016	43.50M	Options	—	Apr 13
Form 3	—	—	—	—	Oct 15, 2015	—	—	—	—

Showing 2 results

Wayfair Inc.

Investor

Updated Nov 24, 2014

View Quote Details


Form 4	1.53%	35.20K	$22.73	$800.07K	Nov 24, 2014	2.33M	Purchase	—	Nov 20
Form 4	2.00%	45.00K	—	—	Nov 12, 2014	2.30M	Purchase	—	Nov 07
Form 4	0.11%	2.40K	$25.17	$60.41K	Nov 05, 2014	2.25M	Purchase	—	Nov 03
Form 4	19.20%	853.04K	—	—	Oct 08, 2014	5.30M	Purchase	—	Oct 02
Form 3	—	—	—	—	Oct 08, 2014	—	—	—	—

Showing 5 results

Editas Medicine, Inc.

Investor

Updated Feb 09, 2016

View Quote Details


Form 4/A	-38.58%	-3.43M	—	—	Feb 09, 2016	5.46M	Buy-Options	—	Feb 08 - Feb 08
Form 4	-38.58%	-3.43M	—	—	Feb 08, 2016	5.46M	Buy-Options	—	Feb 08 - Feb 08
Form 3	—	—	—	—	Feb 08, 2016	2.04M	—	—	—

Showing 3 results

Arbutus Biopharma Corp

Investor

Updated Jul 12, 2019

View Quote Details


Form 4	—	—	—	—	Jul 12, 2019	—	—	—	—
Form 4	132.80%	664.00K	$100.00	$66.40M	Jan 16, 2018	1.16M	Purchase	—	Jan 12
Form 4	—	500.00K	$100.00	$50.00M	Oct 17, 2017	500.00K	Purchase	—	Oct 16
Form 3	—	—	—	—	Jul 13, 2016	16.01M	—	—	—

Showing 4 results

Myovant Sciences Ltd.

Investor

Updated Jul 12, 2019


Form 4	—	—	—	—	Jul 12, 2019	—	—	—	—
Form 4	6.32%	2.42M	$8.25	$20.00M	Jun 13, 2019	40.77M	Purchase	—	Jun 04
Form 4	2.98%	1.11M	$20.27	$22.50M	Apr 04, 2018	38.34M	Purchase	—	Apr 02
Form 3	—	—	—	—	Oct 26, 2016	37.23M	—	—	—

Showing 4 results

Roivant Sciences Ltd.

Investor

Updated Jun 26, 2023

View Quote Details


Form 4	-14.73%	-13.00M	$9.90	-$128.70M	Jun 26, 2023	75.24M	Sale	—	Jun 22
Form 3	—	—	—	—	Oct 01, 2021	88.24M	—	—	—

Showing 2 results

Urovant Sciences Ltd.

Investor

Updated Jul 12, 2019


Form 4	—	—	—	—	Jul 12, 2019	—	—	—	—
Form 4	0.08%	18.20K	$8.32	$151.38K	Jun 19, 2019	22.86M	Purchase	Scheduled	Jun 17 - Jun 19
Form 4	0.10%	22.01K	$8.06	$177.30K	Jun 14, 2019	22.84M	Purchase	Scheduled	Jun 12 - Jun 14
Form 4	0.09%	21.34K	$8.31	$177.25K	Jun 11, 2019	22.82M	Purchase	Scheduled	Jun 07 - Jun 11
Form 4	0.09%	21.12K	$7.86	$165.95K	Jun 06, 2019	22.80M	Purchase	Scheduled	Jun 04 - Jun 06
Form 4	0.08%	17.75K	$7.83	$138.95K	Jun 03, 2019	22.78M	Purchase	Scheduled	May 30 - Jun 03
Form 4	0.06%	14.48K	$7.63	$110.46K	May 29, 2019	22.76M	Purchase	Scheduled	May 24 - May 29
Form 4	0.09%	19.83K	$8.22	$162.92K	May 23, 2019	22.75M	Purchase	Scheduled	May 21 - May 23
Form 4	0.07%	21.61K	$7.63	$162.88K	May 20, 2019	31.35M	Purchase	—	May 16 - May 20
Form 4	13.38%	2.68M	$14.00	$37.50M	Oct 03, 2018	22.70M	Purchase	—	Oct 01
Form 3	—	—	—	—	Sep 26, 2018	20.03M	—	—	—

Showing 11 results

Axovant Gene Therapies Ltd.

Investor

Updated Jul 12, 2019

View Quote Details


Form 4	—	—	—	—	Jul 12, 2019	—	—	—	—
Form 4	6.71%	6.67M	$1.50	$10.00M	Mar 19, 2019	105.95M	Purchase	—	Mar 18
Form 4	11.20%	10.00M	$1.00	$10.00M	Dec 20, 2018	99.29M	Purchase	—	Dec 18
Form 4	19.05%	14.29M	$1.75	$25.00M	Jun 07, 2018	89.29M	Purchase	—	Jun 05
Form 3	—	—	—	—	Jul 13, 2016	75.00M	—	—	—

Showing 5 results

BridgeBio Pharma, Inc.

Investor

Updated Jun 28, 2019

View Quote Details


Form 4	-73.96%	-75.61M	$17.00	—	Jun 28, 2019	26.62M	Buy-Options	—	Jun 27

Showing 1 results